Texas Senate to Address Delta-8 and Delta-9 THC Products in Public Hearing

The Texas Senate is gearing up for a crucial public hearing on May 29, where the focus will be on deliberating a potential ban on delta-8 and delta-9 THC products. This move, initiated by Texas Lt. Gov. Dan Patrick, aims to reevaluate the legality of these products, which have flourished in Texas since 2019.

Revisiting Legislative Decisions

Lt. Gov. Dan Patrick’s call to action stems from concerns surrounding the legalization of delta-8 and delta-9 THC products in 2019. With a public hearing scheduled later this month, the Texas Senate State Affairs Committee will gather input from stakeholders and the public on the issue.

Legislative Context

In June 2019, Texas legislators passed House Bill 1325, legalizing the sale of consumable hemp products in alignment with federal regulations outlined in the 2018 Farm Bill. Subsequently, the Texas Department of State Health Services began registering retail stores for the sale of hemp-based products. However, concerns have emerged regarding the sale and regulation of products containing delta-8 and delta-9 THC.

Call for Regulation

The upcoming hearing reflects a broader call for enhanced regulation of delta-8 and delta-9 THC products. Texas Lt. Gov. Dan Patrick emphasized the need to “Examine the sale of intoxicating hemp products in Texas,” with a specific focus on protecting minors from exposure to these products.

Industry Perspectives

The potential ban on delta-8 and delta-9 THC products has elicited mixed reactions from industry stakeholders. Shayda Torabi, co-owner of a hemp dispensary in Austin, underscores the importance of regulation to ensure product safety and consumer protection. However, she cautions against an outright ban, advocating for balanced regulation that supports responsible businesses.

Divergent Regulations

The contrast between regulations governing medical cannabis providers and hemp dispensaries has raised concerns among industry players. Nico Richardson, CEO of Texas Original, highlights the disparity in regulatory oversight, emphasizing the need for uniform regulations across the cannabis industry.

Looking Ahead

As the Texas Senate prepares to address the issue of delta-8 and delta-9 THC products, stakeholders across the cannabis industry await the outcome of the public hearing. With divergent perspectives and regulatory challenges to navigate, the path forward remains uncertain. However, the upcoming hearing represents a crucial step in shaping the future of cannabis regulation in Texas.